Agenus stock doubles as biotech narrows Phase 3 bet
Agenus stock doubles as biotech narrows Phase 3 bet
Agenus stock doubles as biotech narrows Phase 3 bet
Summary aggregated from Yahoo Finance's public RSS feed. The full reporting belongs to Yahoo Finance — please read it on their site.